Variable | Category | N | Frequency % | Mean | Missing | ||||
Age | Study Group | Cohort Group | Study Group | Cohort Group | Study Group | Cohort Group | Study Group | Cohort Group | |
60.4 | 62.1 | 0 | 0 | ||||||
<55 years | 19 | 12 | 35.8 | 33.3 | |||||
56 - 65 years | 18 | 12 | 34.0 | 33.3 | |||||
66 - 75 years | 7 | 7 | 13.2 | 19.4 | |||||
76 - 85 years | 7 | 1 | 13.2 | 2.8 | |||||
≥86 years | 2 | 4 | 3.8 | 11.1 | |||||
Gender | -- | -- | 0 | 0 | |||||
Male | 27 | 20 | 50.9 | 55.6 | |||||
Female | 26 | 16 | 49.1 | 44.4 | |||||
Initial Systolic BP | 206.5 | 185.9 | 0 | 0 | |||||
Stage 1 Hypertension (SBP ≤ 140) | 4 | 2 | 7.5 | 5.6 | |||||
Stage 2 Hypertension (SBP 141 - 160) | 4 | 8 | 7.5 | 22.2 | |||||
Stage 3 Hypertension (SBP 161 - 180) | 4 | 3 | 7.5 | 8.3 | |||||
Stage 4 Hypertension (SBP 181 - 210) | 13 | 14 | 24.5 | 38.9 | |||||
Exceeds Stage 4 Hypertension | 28 | 9 | 52.8 | 25.0 | |||||
Initial Diastolic BP | 120.4 | 96.0 | 0 | 0 | |||||
Stage 1 Hypertension (DBP ≤ 90) | 4 | 18 | 7.5 | 50.0 | |||||
Stage 2 Hypertension (SBP 91 - 100) | 9 | 4 | 17 | 11.1 | |||||
Stage 3 Hypertension (SBP 101 - 110) | 9 | 5 | 17 | 13.9 | |||||
Stage 4 Hypertension (SBP 111 - 120) | 6 | 4 | 11.3 | 11.1 | |||||
Exceeds Stage 4 Hypertension | 25 | 5 | 47.2 | 13.9 | |||||
Controlled BP | -- | -- | 0 | 7 | |||||
Yes | 52 | 28 | 98.1 | 77.8 | |||||
No | 1 | 1 | 1.9 | 2.8 | |||||
Time to first dose of Cardene | 51.8 | 84.7 | 1 | 0 | |||||
No Cardene given | 0 | 9 | 0 | 25.0 | |||||
1 - 60 minutes | 36 | 8 | 67.9 | 22.2 | |||||
61 - 360 minutes | 16 | 18 | 30.2 | 50.0 | |||||
Time to control BP | 175.4 | 91.4 | 0 | 1 | |||||
BP control not reached | 0 | 1 | 0 | 2.8 | |||||
1 - 60 minutes | 7 | 8 | 13.2 | 22.2 | |||||
61 - 360 minutes | 42 | 18 | 79.2 | 50.0 |